Brokerages Set Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Target Price at $63.67
Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) have received a consensus recommendation of “Buy” from the seven research firms that are currently covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a hold recommendation, five have given a buy recommendation and one has assigned a strong buy […]
Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) have received a consensus recommendation of “Buy” from the seven research firms that are currently covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a hold recommendation, five have given a buy recommendation and one has assigned a strong buy […]
